Douglas M. Salzwedel

2176 Health Science Mall, V6T 1Z3
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.

Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.

Journal: BMJ open diabetes research & care

Published: April 20, 2026

Beta-Blocker Discontinuation in Heart Failure with Preserved or Improved Ejection Fraction: A Systematic Review.

Beta-Blocker Discontinuation in Heart Failure with Preserved or Improved Ejection Fraction: A Systematic Review.

Journal: Journal of cardiac failure

Published: March 27, 2026

Beta-Blocker Discontinuation in Acute Heart Failure: A Systematic Review and Meta-Analysis.

Beta-Blocker Discontinuation in Acute Heart Failure: A Systematic Review and Meta-Analysis.

Journal: JACC. Advances

Published: December 05, 2025

Beta-Blocker Discontinuation After Myocardial Infarction: A Systematic Review and Meta-Analysis.

Beta-Blocker Discontinuation After Myocardial Infarction: A Systematic Review and Meta-Analysis.

Journal: JACC. Advances

Published: December 05, 2025

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.

Journal: The Cochrane database of systematic reviews

Published: April 16, 2025

Blood pressure targets for hypertension in people with chronic renal disease.

Blood pressure targets for hypertension in people with chronic renal disease.

Journal: The Cochrane database of systematic reviews

Published: October 15, 2024

Measuring Quality of Life in Deprescribing Trials: A Scoping Review.

Measuring Quality of Life in Deprescribing Trials: A Scoping Review.

Journal: Drugs & aging

Published: March 17, 2024

Digital interventions to reduce social isolation and loneliness in older adults: An evidence and gap map.

Digital interventions to reduce social isolation and loneliness in older adults: An evidence and gap map.

Journal: Campbell systematic reviews

Published: November 29, 2023

First-line diuretics versus other classes of antihypertensive drugs for hypertension.

First-line diuretics versus other classes of antihypertensive drugs for hypertension.

Journal: The Cochrane database of systematic reviews

Published: July 13, 2023

PROTOCOL: In-person interventions to reduce social isolation and loneliness: An evidence and gap map.

PROTOCOL: In-person interventions to reduce social isolation and loneliness: An evidence and gap map.

Journal: Campbell systematic reviews

Published: June 26, 2023

PROTOCOL: Digital interventions to reduce social isolation and loneliness in older adults: An evidence and gap map.

PROTOCOL: Digital interventions to reduce social isolation and loneliness in older adults: An evidence and gap map.

Journal: Campbell systematic reviews

Published: March 13, 2023

Effects of Social Prescribing for Older Adults: An Evidence and Gap Map.

Effects of Social Prescribing for Older Adults: An Evidence and Gap Map.

Journal: Campbell systematic reviews

Published: November 21, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026